Estimation of the frequencies of anti-mage-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 538-542

  Chaux, Pascal ^a,b   Vantomme, Valérie ^a,b   Coulie, Pierre ^b   Boon, Thierry ^a,b   Van der Bruggen, Pierre ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7;

ARTICLE; CANCER DIAGNOSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; GENE EXPRESSION; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; MELANOMA; PRECURSOR; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031874257     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<538::AID-IJC11>3.0.CO;2-2     Document Type: Article

References (18)

1. ALTMAN, J.D., MOSS, P.A.H., GOULDER, P.J.R., BAROUCH, D.H., MCHEYZER-WILLIAMS, M.G., BELL, J.I., MCMICHAEL, A.J. and DAVIS, M.M., Phenotypic analysis of antigen-specific T lymphocytes. Science, 274, 94-96 (1996).
2. BEVERLEY, P.C., Human T cell subsets. Immunol. Lett., 14, 263-267 (1987).
3. BRASSEUR, F. and 29 OTHERS, Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63, 375-380 (1995).
4. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. nat. Acad. Sci. (Wash.), 91, 2105-2109 (1994).
5. DE PLAEN, E. and 14 OTHERS, Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
6. GAGLIARDI, M.C., DE PETRILLO, G., SALEMI, S., BOFFA, L., LONGOBARDI, M.G., DELLABONA, P., CASORATI, G., TANIGAKI, N., HARRIS, R., LANZAVECCHIA, A. and BARNABA, V., Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol., 7, 1741-1752 (1995).
7. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHÉ, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
8. HAIGHT, F.A., Handbook of the Poisson distribution, J. Wiley, New York (1967).
9. HERMAN, J., VAN DER BRUGGEN, P., LUESCHER, I., MANDRUZZATO, S., ROMERO, P., THONNARD, J., FLEISCHHAUER, K., BOON, T. and COULIE, P.G., A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognized tumor cells expressing MAGE-3. Immunogenetics, 43, 377-383 (1996).
10. + T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J. Immunol. Methods, 203, 141-152 (1997).
11. + T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods, 191, 131-142 (1996).
12. MARCHAND, M. and 20 OTHERS, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
13. SALTER, R.D., HOWELL, D.N. and CRESSWELL, P., Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21, 235-246 (1985).
14. TAKAHASHI, K., SHICHIJO, S., NOGUCHI, M., HIROHATA, M. and ITOH, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55, 3478-3482 (1995).
15. TANAKA, F., FUJIE, T., TAMARA, K., MORI, M., TAKESAKO, K., SETTE, A., CELIS, E. and AKIYOSHI, T., Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocyte antigen-A24. Cancer Res., 57, 4465-4468 (1997).
16. VAN DEN EYNDE, B. and VAN DER BRUGGEN, P., T cell-defined tumor antigens. Curr. Opin. Immunol., 9, 684-693 (1997).
17. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.G., BOËL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994).
18. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).